Market Research Logo

Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019

Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019

The Global Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 report.

This report provides details of the latest option and evaluation agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of option and evaluation agreements from 2014 to 2019.

There are two major forms of deal term that allow a party to a deal to secure rights to an asset subject to a future event namely, option and evaluation.

Evaluation agreements allow a party to the deal to obtain rights to a technology or compound, subject to a period of time to evaluate the quality, scope and applicability of the technology to its intended endpoint.Normally the technology is at an early stage and/or unproven and the partnering companywishes to assess the technology as part of the due diligence process in advance of signing a long term licensing agreement.

Evaluation agreements have been a mainstay of technology licensing from the earliest days.

An option agreement differs in that the option is often an integral part of an agreement already entered by the parties, providing the party with the option right to retain or extend certain rights to the technology already partnered.

Option agreements are becoming increasingly popular as they create additional flexibility within a deal for additional rights that the parties do notwish to commit at the outset of the agreement.

This report focuses on option and evaluation agreements and clauses within broader agreements between big pharma-big pharma, big pharma – smaller company, and smaller company-smaller company, providing a detailed insight into all such deals.

The report provides a detailed understanding and analysis of how and why companies enter option and evaluation deals. The majority of deals are multicomponent whereby the licensor retains either a option and evaluation right to the resultant product of the research collaboration. There are also numerous pure option and evaluation deals whereby the products originator takes on a partner in order to advance the product or compound to a point where the licensee might seek to proceed to a licensing deal.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of all option and evaluation deals announced since 2014 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual option and evaluation contract documents as submitted to the Securities Exchange Commission by companies and their partners.

Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

The initial chapters of this report provide an orientation of option and evaluation dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in option and evaluation as well as a discussion on the merits of the type of deal.

Chapter 3 provides an overview of the structure of option and evaluation deals. The chapter includes numerous case studies to enable understanding of both pure option and evaluation deals and multicomponent deals where option and evaluation forms a part.

Chapter 4 provides a review of the leading option and evaluation deals since 2014. Deals are listed by headline value, signed by big pharma and big biotech and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive listing of the top 50 most active option and evaluation dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.

Chapter 6 provides a comprehensive and detailed review of option and evaluation deals signed and announced since 2014 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the option and evaluation deal.

In addition the report includes a series of appendices containing a comprehensive listing of all option and evaluation deals announced since 2014.

Each listing is organized as an appendix by company A-Z, stage of development at signing, and therapeutic area. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report includes deals announced by hundreds of life science companies including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche, Sanofi, Shire, Takeda, Teva, and Valeant, amongst many others.

The report also includes numerous tables and figures that illustrate the trends and activities in option and evaluation dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about option and evaluation alliances.

Key benefits

Global Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 provides the reader with the following key benefits:

In-depth understanding of option and evaluation deal trends since 2014
Analysis of the structure of option and evaluation agreements with numerous real life case studies
Comprehensive access to over 1,000 actual option and evaluation deals entered into by the world’s biopharma companies
Detailed access to actual option and evaluation contracts enter into by the leading fifty big pharma companies
Insight into the terms included in a option and evaluation agreement, together with real world clause examples
Understand the key deal terms companies have agreed in previous deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

Global Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 is intended to provide the reader with an in-depth understanding of the option and evaluation trends and structure of deals entered into by leading biopharma companies worldwide.

Global Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 includes:

Trends in option and evaluation dealmaking in the biopharma industry since 2014
Analysis of option and evaluation deal structure
Case studies of real-life option and evaluation deals
Access to over 1,000 option and evaluation deal records
The leading option and evaluation deals by value since 2014
Most active option and evaluation dealmakers since 2014
The leading option and evaluation partnering resources

In Global Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019, the available deals are listed by:

Company A-Z
Headline value
Stage of development at signing
Therapeutic area
Technology type

Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.

The Global Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 report provides comprehensive access to available records for over 1,000 option and evaluation deals, including contract documents where available. Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How aresalesand payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?


  • Executive Summary
  • Introduction
  • Trends in option and evaluation dealmaking
    • Introduction
    • Difference between option and evaluation deals
      • Types of option agreement
    • Trends in option and evaluation deals since 2010
      • Option and evaluation dealmaking by year, 2014 to 2019
      • Option and evaluation dealmaking by phase of development, 2014 to 2019
      • Option and evaluation dealmaking by industry sector, 2014 to 2019
      • Option and evaluation dealmaking by therapy area, 2014 to 2019
      • Option and evaluation dealmaking by technology type, 2014 to 2019
      • Option and evaluation dealmaking by most active company, 2014 to 2019
    • Option-based deals
      • Attributes of option-based deals
      • Reasons for entering an option-based deal
      • Uptake of option exercise
      • The future of option-based deals
    • Co-promotion options
      • Attributes of co-promotion in multi-component deals
      • Reasons for including co-promotion options in a deal
      • Uptake of co-promotion rights
      • Co-promotion rights as bargaining chips
      • The future of co-promotion as part of multicomponent deals
    • Company acquisition options
      • Case study 1: Cephalon - Ception
      • Case study 2: Endo - Indevus
      • The future of option to acquire deals
  • Overview of option and evaluation deal structure
    • Introduction
    • Option and evaluation agreement structure
      • Example evaluation agreements
      • Case study 3: Idenix Pharmaceuticals - Janssen Pharmaceuticals
    • Option agreement structure
      • Example option agreements
      • Option to license
      • Case study 4: Biogen Idec - Isis Pharmaceuticals
      • Option to extend/expand applications/territories
      • Case study 5: Novartis -Prometheus
      • Option to finance
      • Case study 6: Amarantus BioSciences- Power3 Medical Products
      • Option to co-promote
      • Case study 7: Teva - OncoGenex Pharmaceuticals
      • Option to manufacture/supply
      • Case study 8: NPS Allelix - Nycomed
    • Option to acquire agreement structure
      • Example acquisition option clauses
      • Case study 9: ViroPharma- Meritage Pharma
      • Case study 10: Nuvasive - Progentix Orthobiology
  • Leading option and evaluation deals
    • Introduction
    • Top option and evaluation deals by value
      • Table Top option and evaluation deals by value since 2014
  • Top 25 most active option and evaluation dealmakers
    • Introduction
    • Top 25 most active option and evaluation dealmakers
      • Table Most active option and evaluation dealmakers 2014 to 2019
      • Merck and Co
      • Celgene
      • Bristol-Myers Squibb
      • Pfizer
      • Takeda Pharmaceutical
      • AstraZeneca
      • Sanofi
      • Abbvie
      • Janssen Biotech
      • Novartis
      • Roche
      • Amgen
      • Biogen
      • Eli Lilly
      • Genentech
      • Janssen Pharmaceuticals
      • MedImmune
      • Boehringer Ingelheim
      • Johnson & Johnson Innovation
      • X-chem
      • Astellas Pharma
      • GlaxoSmithKline
      • Ferring Pharmaceuticals
      • MD Anderson Cancer Center
      • Sarepta Therapeutics
  • Option and evaluation contracts directory
    • Introduction
    • Option andevaluation deals with contracts 2014 to 2019
  • Appendices
    • Option and evaluation dealmaking by companies A-Z
      • 4D Molecular Therapeutics
      • 4D Pharma
      • AADi
      • Abbott Laboratories
      • Abbvie
      • AbClon
      • Abide Therapeutics
      • Abingworth Management
      • Ablynx
      • Abyrx
      • Achaogen
      • Acucela
      • AC Immune
      • Adapsyn Bioscience
      • Adaptimmune
      • Adaptive Biotechnologies
      • Adare Pharmaceuticals
      • ADC Therapeutics
      • Addex Therapeutics
      • Adimab
      • AdoRx Therapeutics
      • Aduro BioTech
      • Advanced Accelerator Applications
      • Advanced Cardiac Therapeutics
      • Advanced Proteome Therapeutics
      • Advaxis
      • Aegis Therapeutics
      • Aerie Pharmaceuticals
      • AEterna Zentaris
      • Aevi Genomic Medicine
      • Affectis Pharmaceuticals
      • Affibody
      • Agensys
      • Agenus Bio
      • Agios Pharmaceuticals
      • AgonOx
      • AIMM Therapeutics
      • Akcea Therapeutics
      • Akkadeas Pharma
      • Albumedix
      • Alcyone Lifesciences
      • Aldeyra Therapeutics
      • Alector
      • Alexion Pharmaceuticals
      • Alivio Therapeutics
      • Allergan
      • Allogene Therapeutics
      • Almirall
      • Alnylam Pharmaceuticals
      • ALRISE Biosystems
      • ALS Association
      • Alteogen
      • Altos Group
      • AM-Pharma
      • Amag Pharmaceuticals
      • Amarantus BioSciences
      • Amarillo Biosciences
      • Ambys Medicines
      • Amgen
      • AmorChem
      • Amorsa Therapeutics
      • Amunix
      • Amyris
      • Anacor Pharmaceuticals
      • Anaeropharma
      • Anatara Lifesciences
      • AnGes MG
      • Angiodynamics
      • Angionetics
      • Anokion
      • Apceth
      • Apeiron Biologics
      • Apexigen
      • Apricus Biosciences
      • Aptose Biosciences
      • APT Therapeutics
      • Arch Biopartners
      • Arcturus Therapeutics
      • Arcus Biosciences
      • Arcutis
      • Ardelyx
      • ArGEN-X
      • Argenx
      • Ariad Pharmaceuticals
      • ArQule
      • Arrowhead Pharmaceuticals
      • Arrow Pharmaceuticals
      • Artelo Biosciences
      • Arthrex
      • Arvinas
      • Asahi Kasei
      • Ascenion
      • ASKA Pharmaceuticals
      • Aslan Pharma
      • Astellas Pharma
      • Asterias Biotherapeutics
      • AstraZeneca
      • Atara Biotherapeutics
      • Athersys
      • Atlab Pharma
      • Atomwise
      • Audion Therapeutics
      • Aurigene Discovery Technologies
      • Aurinia Pharmaceuticals
      • Auris Medical
      • Autifony Therapeutics
      • Auxogyn
      • Avacta
      • Avalanche Biotechnologies
      • AVEO Oncology
      • Avista Pharma Solutions
      • Basilea Pharmaceutica
      • Bassett Salon Solutions
      • Bavarian Nordic
      • Baxalta
      • Baxter International
      • Bayer
      • Bayer Healthcare
      • Beacon Discovery
      • Beam Therapeutics
      • BeiGene
      • Bellicum Pharmaceuticals
      • Beta Therapeutics
      • Bio-Path
      • Bio-Techne
      • BioArctic Neuroscience
      • BioAtla
      • Biocept
      • BioCorRx
      • Biodel
      • BioDuro
      • Biogen
      • Biohaven Pharmaceutical Holding
      • Bioject Medical Technologies
      • BiolineRX
      • Biomecite Diagnostics
      • BioNTech
      • Bioprocess Capital Ventures
      • BioRap Technologies
      • BioSense Global
      • BioSig Technologies
      • Biotest
      • Biothera
      • BioTheranostics
      • BioTime
      • Bioverativ
      • BlinkBio
      • Bluebird Bio
      • Blueprint Medicines
      • Boehringer Ingelheim
      • BoneSupport
      • Bone Biologics
      • Boston Scientific
      • Boston Therapeutics
      • Boston University School of Medicine
      • Braeburn Pharmaceuticals
      • Brigham and Women's Hospital
      • Brii Biosciences
      • BRIM Biotechnology
      • Bristol-Myers Squibb
      • Broad Institute
      • Bruker
      • Buck Institute for Age Research
      • C4 Therapeutics
      • Caelum Biosciences
      • Calico
      • California Institute for Biomedical Research
      • California Institute for Quantitative Biosciences (QB3)
      • Calithera Biosciences
      • Calyxt
      • Camarus
      • Canadian Brain Tumour Consortium
      • Canbex Therapeutics
      • Cancer Genetics
      • Cancer Prevention Pharmaceuticals
      • Cancer Research Institute
      • Cancer Research Technology
      • Cancer Research UK
      • Canigma
      • Capricor Therapeutics
      • Cardiff University
      • Cardinal Partners
      • Caribou Biosciences
      • Catalent Pharma Solutions
      • Cedars-Sinai Medical Center
      • Celgene
      • Celimmune
      • Celladon
      • Celldex Therapeutics
      • Cellectar Biosciences
      • Cellectis
      • Cellect Biotechnology
      • Cellmid
      • Celltrion
      • Cell Medica
      • Cell Therapy Catapult
      • Celularity
      • Celyad
      • Censa Pharmaceuticals
      • Centers for Disease Control and Prevention
      • Centre for Imaging Technology Commercialization
      • Centre For The Commercialization Of Antibodies And Biologics
      • Cephea Valve Technologies
      • Cerulean Pharma
      • Cesca Therapeutics
      • Charcot-Marie-Tooth Association
      • ChemoCentryx
      • Chromocell
      • CIMAB SA
      • Cincinnati Children's Hospital Medical Center
      • Circassia
      • Clearside Biomedical
      • Cleveland BioLabs
      • Cleveland Clinic
      • CNA Development
      • Coalition for Epidemic Preparedness Innovations
      • Cochlear
      • Cocoon Biotech
      • Codexis
      • Complement Pharma
      • Compugen
      • Conatus Pharmaceuticals
      • Concortis Biosystems
      • Convergence Pharmaceuticals
      • COPD Foundation
      • Copenhagen University Hospital
      • Cordis
      • Crescendo Biologics
      • CRISPR Therapeutics
      • Cryolife
      • CrystalGenomics
      • CSL
      • CSL Behring
      • CTX Technology
      • Curis
      • Cutanogen
      • CymaBay Therapeutics
      • Cynata Therapeutics
      • CytomX Therapeutics
      • Cytoo
      • Daiichi Sankyo
      • DanDrit Biotech
      • Dare Bioscience
      • Dauntless Pharmaceuticals
      • Debiotech
      • Decibel Therapeutics
      • Deinove
      • Denali Therapeutics
      • DendroCyte
      • Department of Veterans Affairs
      • Dermelix Biotherapeutics
      • Dermira
      • DermSpectra
      • De Duve Institute
      • DiamiR
      • Dicerna Pharmaceuticals
      • DigiPath Solutions
      • Dimerix Biosciences
      • Domain Therapeutics
      • Dow AgroSciences
      • Dragonfly Therapeutics
      • DSM
      • Duke University
      • Dynavax Technologies
      • Eagle Pharmaceuticals
      • EastGate Biotech
      • Easton Pharmaceuticals
      • EDAP TMS
      • Edico Genome
      • Edison Nation Medical
      • Editas Medicine
      • EFFECTOR Therapeutics
      • Eisai
      • Eisai S.A.S
      • Eleven Biotherapeutics
      • Eli Lilly
      • EmboMedics
      • Emergent BioSolutions
      • Emisphere
      • Emory University
      • Enable Injections
      • Endo Pharmaceuticals
      • ENeura Therapeutics
      • EnGene
      • EnGeneIC
      • Enteris Biopharma
      • Enterome Bioscience
      • Eppin Pharma
      • Ergomed
      • ERS Genomics
      • Establishment Labs
      • ETheRNA immunotherapies
      • Eticann S.A.S. Zomac
      • Eureka Therapeutic
      • European Organization for Research and Treatment of Cancer
      • Evestra
      • Evotec
      • Evox Therapeutics
      • Exelixis
      • Exicure
      • Exovita Biosciences
      • ExScientia
      • EyeMedics
      • F-Star
      • F-Star Alpha
      • Facit
      • Fagron
      • FairJourney Biologics
      • Fate Therapeutics
      • Ferring Pharmaceuticals
      • Five Prime Therapeutics
      • FKD Therapies
      • FOB Synthesis
      • Fondazione Telethon
      • Food and Drug Administration (FDA)
      • Foresee Pharmaceuticals
      • FORMA Therapeutics
      • Fox Chase Cancer Center
      • Fscan
      • Fujifilm
      • Fujifilm medical systems
      • FX Therapeutics
      • G-treeBNT
      • G2B Pharma
      • G3 Pharmaceuticals
      • Gadeta
      • Galapagos
      • Galaxy Biotech
      • Galecto Biotech
      • Galmed Pharmaceuticals
      • GamaMabs Pharma
      • Gamida Cell
      • GammaDelta Therapeutics
      • GEn1E Lifesciences
      • Genentech
      • GenePeeks
      • Genesee BioMedical
      • Genethon
      • GeNeuro
      • Genexine
      • Genisphere
      • Genmab
      • GenVec
      • Genzyme
      • Georgetown University
      • Georgetown University Hospital
      • George Washington University
      • GeoVax
      • German Cancer Research Center
      • Geron
      • GE Healthcare
      • Gilead Sciences
      • GlaxoSmithKline
      • Glenmark Pharmaceuticals
      • Glide
      • Globavir Biosciences
      • Glycotope Biotechnology
      • Glykos
      • GOG Foundation
      • GrayBug
      • Gritstone Oncology
      • Grunenthal
      • GW Pharmaceuticals
      • H3 Biomedicine
      • Hadasit Medical Research Services and Development
      • Haga Teaching Hospital
      • Haibo Biotechnology Institute
      • Hancock Jaffe Laboratories
      • Hanmi Pharmaceutical
      • Hannover Medical School
      • Harpoon Therapeutics
      • Harvard Stem Cell Institute
      • Harvard University
      • HEC Pharm
      • HedgePath Pharmaceuticals
      • Heidelberg Pharma
      • Helius Medical Technologies
      • Helmholtz Zentrum Munchen
      • HemispheRx Biopharma
      • Henlius Biotech
      • Henry Ford Health System
      • HiFiBio
      • HistoIndex
      • Hoffmann La Roche
      • Horizon Discovery
      • Horizon Pharma plc
      • Horus Pharma
      • Hospices Civils de Lyon
      • Humanetics
      • Hutchison MediPharma
      • Icahn School of Medicine at Mount Sinai
      • Idera Pharmaceuticals
      • Idorsia
      • IGNITE Immunotherapy
      • IHI
      • ILTOO Pharma
      • Imab
      • Imaxio
      • Imbrium Therapeutics
      • Imcyse
      • Immatics Biotechnologies
      • Immucor
      • Immune Design
      • ImmunID Technologies
      • ImmunoBiochem
      • ImmunoCellular Therapeutics
      • Immunocore
      • ImmunoGen
      • Immunomedics
      • Immunomic
      • Imperial Innovations
      • Inception 5
      • Inception Sciences
      • Incuron
      • Incyte
      • Infinity Pharmaceuticals
      • Infuseon Therapeutics
      • Innate Pharma
      • Innovasource
      • Innovent Biologics
      • Innovet
      • Inovio Pharmaceuticals
      • Inserm Transfert
      • Insmed Inc
      • Institute of Cancer Research
      • Institut Pasteur
      • Intec
      • Intellia Therapeutics
      • International Stem Cell
      • Intrexon
      • INtRON Biotechnology
      • Ionis Pharmaceuticals
      • Iovance Biotherapeutics
      • Ipsen
      • ISA Pharmaceuticals
      • ISense CGM
      • ISIS Innovation
      • Isogenica
      • ITM Isotopen Technologien
      • Janssen Biotech
      • Janssen Pharmaceuticals
      • Janssen Research & Development
      • Jazz Pharmaceuticals
      • JFE Engineering
      • Jiangsu Hengrui Medicine
      • Johnson & Johnson
      • Johnson & Johnson Innovation
      • Johns Hopkins Medicine (JHM)
      • Johns Hopkins University
      • Joslin Diabetes Center
      • Jounce Therapeutics
      • Juno Therapeutics
      • Jupiter Orphan Therapeutics
      • Juventas Therapeutics
      • Kairos Therapeutics
      • Kaiser Permanente
      • KAI Research
      • Kaken Pharmaceutical
      • Kallyope
      • KalVista Pharmaceuticals
      • Kanyos
      • Karolinska Institute
      • Keck School of Medicine of USC
      • KineMed
      • Kineta
      • Kite Pharma
      • Klaria
      • Knopp Biosciences
      • Kochoptik
      • KSF Acquisition
      • Kymab
      • Kyn Therapeutics
      • Kyowa Hakko Kirin
      • Lantheus Medical Imaging
      • La Jolla Pharmaceutical
      • Lead Discovery Center
      • Lee Moffitt Cancer Center
      • Leidos
      • Leon-nanodrugs
      • LEO Pharma
      • Lexicon Pharmaceuticals
      • LFB Biotechnologies
      • LG Life Sciences
      • Lockheed Martin
      • Lonza
      • Ludwig Institute for Cancer Research
      • Lunenfeld-Tanenbaum Research Institute
      • Lunit
      • Lupin Limited
      • Lycera
      • Lynkogen
      • Lysogene
      • MabVax Therapeutics
      • Macrogenics
      • Magenta Therapeutics
      • Mallinckrodt Pharmaceuticals
      • Mannin Research
      • Massachusetts General Hospital
      • Mauna Kea Technologies
      • Maverick Therapeutics
      • Max-Planck
      • Mayo Clinic
      • MBI
      • MDRM Group (Canada)
      • MD Anderson Cancer Center
      • MedGenesis Therapeutix
      • Medgenics
      • Medherant
      • Medical Prognosis Institute
      • Medical University South Carolina
      • MediciNova
      • Medidata Solutions
      • Medifocus
      • MediGene
      • MedImmune
      • Medizone International
      • MED Institute
      • MEI Pharma
      • Memorial Sloan Kettering Cancer Center
      • Merck and Co
      • Merck KGaA
      • Merck Serono
      • Merck Sharpe & Dohme
      • Mereo BioPharma
      • Merus
      • Mesoblast
      • Mezzion Pharma
      • Microbiotica
      • Midatech
      • Millipede
      • MiniVax
      • Minneapolis Medical Research Foundation
      • Mirati Therapeutics
      • Mitsubishi Tanabe Pharma
      • Moderna Therapeutics
      • Modern Mobility Aids
      • Monopar Therapeutics
      • Monsanto
      • Morphic Therapeutic
      • MorphoSys
      • Morphotek
      • Mount Sinai Health System
      • MultiCell Immunotherapeutics
      • Mundipharma
      • Murdoch Childrens Research Institute
      • MyBiotics Pharma
      • Mylan Laboratories
      • Mymetics
      • Myonexus Therapeutics
      • Myriad Genetics
      • Nanobeak
      • Nanobiotix
      • NanoString Technologies
      • NanoViricides
      • NantBioScience
      • Nantes University
      • NantPharma
      • Nanyang Technological University
      • Natera
      • National Cancer Institute
      • National Center for Tumor Diseases
      • National Heart, Lung and Blood Institute
      • National Institutes of Health
      • National Institutes of Health Center for Regenerative Medicine
      • National Institute of Allergy and Infectious Diseases
      • National Institute on Alcohol Abuse and Alcoholism (NIAAA)
      • National Institute on Drug Abuse (NIDA)
      • Nationwide Children's Hospital
      • Navidea Biopharmaceuticals
      • Nektar Therapeutics
      • Nemucore Medical Innovations
      • NeoImmuneTech
      • Neomed Institute
      • Neon Therapeutics
      • Neovacs
      • Nestle Health Science
      • Netherlands Cancer Institute
      • NeuMoDx Molecular
      • NeuroSigma
      • NeuroVive Pharmaceutical
      • Nevada Center For Behavioral Health
      • Newlink Genetics
      • New England Research Institutes
      • New York State
      • NextCure
      • Nextera
      • NGM Biopharmaceuticals
      • Nicox
      • Nihon Medi-Physics
      • Nimbus Therapeutics
      • Nodality
      • Noile-Immune Biotech
      • Nordic Nanovector
      • Northern Biologics
      • Northwestern University
      • NovaMedica
      • Novartis
      • Novozymes Biopharma
      • Novo Nordisk
      • Noxxon Pharma
      • Nrgene
      • Nuevolution
      • Nuformix
      • NuGene International
      • Numab
      • Nuo Therapeutics
      • Nurix
      • Obsidian Therapeutics
      • Ocular Therapeutics
      • Ohr Pharmaceuticals
      • Omeros
      • OncoImmune
      • Oncology Venture
      • OncoSec Medical
      • Oncosynergy
      • OnDosis
      • One Way Liver Genomics (OWL)
      • Ono Pharmaceutical
      • Ophthotech
      • OPKO Health
      • OptiBiotix
      • Oraxion Therapeutics
      • Orbis
      • Orbit Biomedical
      • Orca Pharmaceuticals
      • Orchard Therapeutics
      • Oregon Health Sciences University
      • ORFLO Technologies
      • Organic Vaccines
      • Organogenesis
      • Orion
      • Orthofix
      • OSE Immunotherapeutics
      • Ossianix
      • Oswaldo Cruz Foundation (Fiocruz)
      • Oxford BioTherapeutics
      • Oxford Genetics
      • Oxis Biotech
      • Oxurion
      • Pacific Edge Biotechnology
      • Pairwise Plants
      • Panion
      • Panther Biotechnology
      • Parion Sciences
      • PellePharm
      • Pepsico
      • PeptiDream
      • PeptiMimesis
      • PerkinElmer
      • Pfenex
      • Pfizer
      • Pharmacyclics
      • PharmaJet
      • Pharmatech
      • Pherin Pharmaceuticals
      • Philogen
      • PhoreMost
      • Phosplatin Therapeutics
      • Phylogica
      • PhysIQ
      • PhytoTech Medical
      • Pieris
      • Pierre Fabre
      • Piqur Therapeutics
      • Plant Bioscience Limited
      • Potenza Therapeutics
      • Precision BioSciences
      • Premune
      • PreveCeutical Medical
      • Prime Therapeutics
      • ProBioGen
      • Pronutria
      • Protein Sciences
      • Proteomics International
      • Prothelia
      • Prothena Biosciences
      • PSivida
      • Pulmatrix
      • Purdue Pharma
      • Puregraft
      • Puridify
      • PvP Biologics
      • Qiagen
      • QT Vascular
      • Quad Technologies
      • Quark Venture
      • Quartet Medicine
      • Queensland Institute of Medical Research (QIMR)
      • Quotient Clinical
      • Q BioMed
      • Rani Therapeutics
      • Rappaport Research Institute
      • Raptor Pharmaceutical
      • Recursion Pharmaceuticals
      • RedHill Biopharma
      • Regeneron Pharmaceuticals
      • Regenerx
      • Regenesys
      • Regenxbio
      • Regulus Therapeutics
      • Reproductive Medicine Associates of New York
      • Resolution Bioscience
      • Respicardia
      • RESprotect
      • Resverlogix
      • Retrophin
      • Revolution Medicines
      • REVO Biologics
      • Rexahn Pharmaceuticals
      • Robert H. Lurie Comprehensive Cancer Center
      • Roche
      • Rocket Pharmaceuticals
      • Rockwell Medical
      • Rodin Therapeutics
      • Rohto Pharmaceutical
      • Roivant Sciences
      • Romer Labs
      • Rosetta Genomics
      • Rugen Therapeutics
      • RXi Pharmaceuticals
      • Salix Pharmaceuticals
      • Salud Digna
      • SAMIL Pharm
      • Sandoz
      • Sangamo BioSciences
      • Sanofi-Aventis
      • Sanofi-Pasteur
      • Sanofi
      • Santaris Pharma
      • Santhera Pharmaceuticals
      • San Martino Hospital
      • San Raffaele Scientific Institute
      • San Raffaele Telethon Institute for Gene Therapy
      • Sarepta Therapeutics
      • Scholar Rock
      • Schrodinger
      • ScreenCell
      • Scripps Research Institute
      • Scripps Translational Science Institute
      • Seattle Genetics
      • Selecta Biosciences
      • SemaThera
      • Senexta
      • Senju Pharmaceutical
      • Senomyx
      • Sensorion
      • Sequenom
      • Seres Therapeutics
      • Servier
      • Sevion Therapeutics
      • Shenzhen Chipscreen Biosciences
      • Shenzhen Hepalink Pharmaceutical
      • Shin Nippon Biomedical Laboratories
      • Shionogi
      • Shire Pharmaceuticals
      • Siamab Therapeutics
      • Siemens
      • Singapore Immunology Network
      • SiO2 Medical Products
      • Sirenas
      • Sirona Genomics
      • SkyePharma
      • Skyhawk Therapeutics
      • Small Business Innovation Research
      • SolaranRx
      • Sorin Group
      • Sorrento Therapeutics
      • Sosei
      • Spark Therapeutics
      • Specialised Therapeutics
      • Spero Therapeutics
      • Sphingotec
      • SpineThera
      • SpringWorks Therapeutics
      • Spring Bank Pharmaceuticals
      • Squalan Natural Health
      • St. Jude Children's Research Hospital
      • Stanford University
      • Staten Biotechnology
      • STC.UNM
      • Strategic Science and Technologies
      • Sucampo Pharmaceuticals
      • Summit Therapeutics
      • SurePure
      • Surface Oncology
      • Sutro Biopharma
      • Swedish Orphan Biovitrum
      • Symphogen
      • Synaffix
      • Syndax Pharmaceuticals
      • Synthetic Genomics
      • Syros Pharmaceuticals
      • Taiho
      • Takeda Pharmaceutical
      • Tamarack Biotics
      • Tango Therapeutics
      • TapImmune
      • Targacept
      • Taxus Cardium Pharmaceuticals
      • Techcomp
      • Technology University Dresden
      • Teijin
      • Tekmira Pharmaceuticals
      • Teleflex
      • Telix Pharmaceuticals
      • Tel Aviv University
      • Temple University
      • TeneoBio
      • TeneoOne
      • Terumo BCT
      • Tesaro
      • Tetragenetics
      • Tetra Discovery Partners
      • Therapeia
      • Therapix Bio
      • Theravance
      • The Parker Institute For Cancer Immunotherapy
      • Thomas Jefferson University
      • TiGenix
      • Titan Pharmaceuticals
      • Tiziana Life Sciences
      • Tizona Therapeutics
      • Torque Therapeutics
      • TRACON Pharmaceuticals
      • TransBio
      • Transgenomic
      • Transition Therapeutics
      • Transparency Life Sciences
      • Triphase Accelerator
      • TriReme Medical
      • Trizell
      • True North Laboratory
      • Tsinghua University
      • Tufts University
      • Turnstone Biologics
      • TxCell
      • Tyme Technologies
      • T Med
      • UbiVac
      • Ultragenyx Pharmaceuticals
      • UMN Pharma
      • Unilife
      • UniQuest
      • Universite catholique de Louvain
      • University College London
      • University Medical Center Hamburg-Eppendorf
      • University of California Los Angeles
      • University of California San Francisco
      • University of Chicago
      • University of Cincinnati
      • University of Connecticut
      • University of Florida
      • University of Florida Research Foundation
      • University of Guelph
      • University of Illinois at Chicago
      • University of Leipzig
      • University of Maryland Baltimore
      • University of Maryland Ventures
      • University of Massachusetts, Amherst
      • University of Massachusetts
      • University of Massachusetts Medical School
      • University of Miami
      • University of Minnesota
      • University of Nevada
      • University of New Mexico
      • University of Oxford
      • University of Pennsylvania
      • University of Pittsburgh
      • University of Rochester
      • University of Sydney
      • University of Texas Southwestern Medical Center
      • University of Toronto
      • University of Washington
      • University of Wisconsin
      • US Army
      • US Army Medical Research Institute of Chemical Defense
      • US Army Medical Research Institute of Infectious Diseases
      • US Department of Veteran Affairs
      • US Veterans Administration
      • Vaccinex
      • Valens GroWorks
      • Valneva
      • Vantage Health
      • Vasomune Therapeutics
      • Vaximm
      • VDM Biochemicals
      • Vectura
      • Vedanta Biosciences
      • Velo Bio
      • Ventana Medical Systems
      • VentiRx Pharmaceuticals
      • Verastem
      • Versant Ventures
      • Vertex Pharmaceuticals
      • ViaCyte
      • Vifor-Fresenius Medical Care Renal Pharma Ltd
      • Vifor Pharma
      • Vinnova
      • Virax
      • Viroclinics Biosciences
      • Vir Biotechnology
      • VistaGen Therapeutics
      • Visterra
      • Vitaeris
      • Vitae Pharmaceuticals
      • VitalConnect
      • Vitrisa Therapeutics
      • Vivaldi Biosciences
      • Vivione Biosciences
      • Vivior
      • Vivus
      • Volpara Solutions
      • Voyager Therapeutics
      • Washington University in St Louis
      • WAVE Life Sciences
      • Weill Cornell Medical College
      • Western Oncolytics
      • WinterLight Labs
      • Women & Infants Hospital of Rhode Island
      • X-chem
      • XERIS Pharmaceuticals
      • Xoma
      • Yeda Research and Development Company
      • Yissum Research Development
      • Yonsei University Severance Hospital
      • YouHealth Eyetech
      • ZAI Laboratory
      • ZappRx
      • Zoetis
      • Zomedica
      • Zymeworks
    • Option and evaluation dealmaking by industry sector
      • Academic
      • Agricultural
      • Animal Health
      • Bigbiotech
      • Bigpharma
      • Biotech
      • Consumer health
      • Drug delivery
      • Medical device
      • Diagnostic
      • Financial
      • Generic pharma
      • Government
      • Non-profit
      • Pharmaceutical
      • Research tools
      • Services
      • Specialty pharma
    • Option and evaluation dealmaking by stage of development
      • Discovery
      • Preclinical
      • Phase I
      • Phase II
      • Phase III
      • Regulatory
      • Marketed
      • Formulation
    • Option and evaluation dealmaking by therapy area
      • Breast
      • Cardiovascular
      • Arrhythmia
      • Atrial fibrillation
      • Ventricular tachycardia
      • Atherosclerosis
      • Cardiomyopathy (heart muscle disease)
      • Congenital heart disease
      • Congestive heart failure
      • Coronary artery disease
      • Hypercholesterolemia
      • Hypertension
      • Myocardial Infarction
      • Peripheral arterial disease
      • Valvular heart disease
      • Central Nervous System
      • Creutzfeldt Jakob disease
      • Epilepsy
      • Migraine
      • Motor Neurone Disease (Amyotrophic Lateral Sclerosis/Lou Gehrig's Disease)
      • Multiple sclerosis
      • Neuropathy
      • Pain
      • Fibromyalgia
      • Parkinson's disease
      • Spinal cord
      • Stroke
      • Traumatic Brain Injury
      • Dermatology
      • Burns
      • Cosmetics
      • Dermatitis
      • Diabetic foot ulcer
      • Hair disorders
      • Itching
      • Psoriasis
      • Venous ulcer
      • Wound healing
      • Gastrointestinal
      • Celiac disease
      • Inflammatory bowel disease
      • Crohn's disease
      • Ulcerative colitis
      • Irritable bowel syndrome
      • Malnutrition
      • Bowel movement
      • Genetic disorders
      • Cystic Fibrosis (CF)
      • Huntington's disease
      • Neurofibromatosis
      • Rare genetic disorders
      • Sickle cell disease
      • Genitourinary
      • Acute kidney injury
      • Amyloidosis
      • Chronic kidney disease (CKD)
      • Cystitis
      • Diabetic nephropathy
      • Dialysis
      • Incontinence
      • Polycystic kidney disease
      • Renal failure
      • Renal infections
      • Urinary tract infection (UTI)
      • Gynaecology
      • Endometriosis
      • Fibroids
      • Human papillomavirus (HPV)
      • Menopause
      • Hematology
      • Anemia
      • Hemophilia
      • Thalassemia
      • Von-Willebrand disease
      • Accident and emergency
      • Poisoning
      • Surgery
      • Orthopedics
      • Transplantation
      • Immunology
      • Allergy
      • Anaphylactic shock
      • Other autoimmune
      • Graft versus host disease
      • Inflammation
      • Systemic lupus erythematosus
      • Infectives
      • Bacterial
      • Escherichia Coli (E-coli)
      • Methicillin-resistant Staphylococcus aureus (MRSA)
      • Pseudomonas aeruginosa
      • Sepsis
      • Fungal
      • Dengue fever
      • Viral
      • Cytomegalovirus
      • Ebola
      • B
      • C
      • Herpes simplex
      • HIV
      • Influenza
      • Respiratory syncytial virus (RSV)
      • Zika
      • Metabolic
      • Diabetes
      • Type 1
      • Type 2
      • Growth hormone disorders
      • Phenylketonuria
      • Liver disease
      • Nonalcoholic steatohepatitis (NASH)
      • Lysosomal storage disorders
      • Nutrition and vitamins
      • Musculoskeletal
      • Ankylosing spondylitis
      • Osteoarthritis
      • Psoriatic arthritis
      • Rheumatoid arthritis
      • Muscular dystrophy
      • Back pain
      • Osteoporosis
      • Spinal muscular atrophy
      • Obstetrics
      • Pre-eclampsia
      • Prenatal screening
      • Oncology
      • Bladder cancer
      • Brain cancer
      • Breast cancer
      • Cervical cancer
      • Colorectal cancer
      • Esophageal cancer
      • Gastric cancer
      • Head and neck cancer
      • Kidney cancer
      • Leukemia
      • Acute lymphoblastic leukemia
      • Acute myelogenous leukemia
      • Chronic lymphocytic leukemia
      • Chronic myelogenous leukemia
      • Liver cancer
      • Lung cancer
      • Non small cell lung cancer
      • Small cell lung cancer
      • Lymphoma
      • Hodgkin's lymphoma
      • Non Hodgkin's lymphoma
      • Melanoma
      • Metastases
      • Multiple myeloma
      • Ovarian cancer
      • Pancreatic cancer
      • Prostate cancer
      • Renal cell carcinoma
      • Sarcoma
      • Solid tumors
      • Symptoms
      • Bone
      • Thyroid cancer
      • Ophthalmics
      • Age-related macular degeneration
      • Blindness
      • Cataracts
      • Diabetic macular edema
      • Dry eye
      • Glaucoma
      • Ocular hypertension
      • Retinal detachment
      • Retinopathy
      • Uveitis
      • Orphan disease
      • Pediatrics
      • Psychiatry
      • Generalised anxiety disorder
      • Attention deficit hyperactivity disorder
      • Cognitive impairment
      • Dementia
      • Alzheimers
      • Depression
      • Anorexia
      • Autism
      • Obsessive compulsive disorder
      • Schizophrenia
      • Tourettes
      • Public Health
      • Alcohol
      • Drugs
      • Obesity
      • Respiratory
      • Acute respiratory distress syndrome
      • Asthma
      • Chronic obstructive pulmonary disease
      • Emphysema
      • Idiopathic pulmonary fibrosis
      • Pulmonary arterial hypertension
      • Sensory organs
      • Hearing disorders
      • Hearing loss
      • Contraception
      • Erectile dysfunction
    • Option and evaluation dealmaking by technology type
      • Adjuvant
      • Analysis
      • Animal models
      • Antibiotics
      • Antibodies
      • Antibody-drug conjugate
      • Bispecific antibodies
      • Monoclonal antibodies
      • Chimeric mAb
      • Humanized mAb
      • Human mAb
      • Polyclonal antibodies
      • AI/Artificial intelligence
      • Assays
      • Biodefense
      • Bioinformatics
      • Biological compounds
      • Biomarkers
      • Biomaterials
      • Bioprocessing
      • Blood products
      • Cell culture
      • Clinical testing
      • CRISPR
      • Devices
      • Surgical devices
      • Wearable devices
      • Diagnostics
      • Companion
      • Imaging
      • CT
      • MRI
      • Ultrasound
      • X-ray
      • Angiography
      • In vitro diagnostics
      • Molecular diagnostics
      • Prognostics
      • Discovery tools
      • Compound screening library
      • High throughput screening (HTS)
      • Drug delivery
      • Bioavailability
      • Implantable
      • Oral delivery
      • Delayed release
      • Parenteral
      • Injectable
      • Targeted
      • Topical
      • Transdermal
      • Transmucosal
      • Buccal
      • Inhaled
      • Nasal
      • Ocular
      • Enabling technology
      • Enviromental
      • Epigenetics
      • Equipment
      • Gene therapy
      • Genomics
      • Implant
      • In vitro models
      • Microbiome
      • Nanotechnology
      • Natural product
      • Oligonucleotide
      • Packaging
      • Peptides
      • Personalised medicine
      • Pharmacogenomics
      • Precision medicine
      • Processes
      • Proteomics
      • Radio/Chemo-therapy
      • Recombinant DNA
      • Regenerative medicine
      • Anti-aging
      • Cell therapy
      • Organ regeneration
      • Stem cells
      • Tissue regeneration
      • Research services
      • Research supplies
      • RNA therapeutics
      • Screening
      • Small molecules
      • Software tools
      • Toxicity
      • Vaccines
      • Attenuated vaccine
      • Inactivated vaccine
      • Recombinant vector vaccine
      • Subunit vaccine
  • About Wildwood Ventures
    • Current Partnering
    • Current Agreements
    • Recent report titles from CurrentPartnering

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report